Differential susceptibility of muscles to myotonia and force impairment in a mouse model of Myotonic dystrophy

Muscle and Nerve

Volumn 43, Issue 6, 2011, Pages 818-827

  Moyer, Michelle ^a   Berger, Dara S ^c   Ladd, Andrea N ^c   van Lunteren, Erik ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Diaphragm; EDL; HSALR mouse; Myotonia; Myotonic dystrophy; Soleus

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DISEASE PREDISPOSITION; EXTENSOR DIGITORUM LONGUS MUSCLE; FAST MUSCLE FIBER; MOUSE; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE FATIGUE; MUSCLE FORCE; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; RELAXATION TIME; SOLEUS MUSCLE;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 79957953443     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21988     Document Type: Article

References (48)

1. Harper PS. Myotonic dystrophy. London: W.B. Saunders; 2001.
2. Brook JD, McCurrach ME, Harley HG, Buckler HJ, Church D, Aburantani H, et al. Molecular basis of myotonic dystrophy: expansion of trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
3. Fu YH, Pizzuti A, Fenwick RG Jr, Rajnarayan S, Dunne PW, Dubel J, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.
4. Mahadevan M, Tsilfidis C, Sabourin L, Shutlet G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 30 untranslated region of the gene. Science 1992;255:1253-1255.
5. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867.
6. Kuyumcu-Martinez NM, Cooper TA. Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. Prog Mol Subcell Biol 2006;44:133-159.
7. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000;19:4439-4448.
8. Mankodi A, Urbinate CR, Yuan QP, Moxley RT, Sansone V, Krym M, et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 2001;10:2165-2170.
9. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, et al. Three proteins, MBNL, MBLL and MBXL, co localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 2002;11:805-814.
10. Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing neurons. Hum Mol Genet 2004;13:3079-3088.
11. Dansithong W, Paul S, Comai L, Reddy S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J Biol Chem 2005;280:5773-5780.
12. Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001;29:40-47.
13. Timchenko NA, Cai ZJ, Welm AL, Reddy S, Ashizawa T, Timchenko LT. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001;276:7820-7826.
14. Kuyumcu-Martinez NM, Wang GS, Cooper TA. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 2007;28:68-78.
15. Ladd AN, Taffet G, Hartley C, Kearney DL, Cooper TA. Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol Cell Biol 2005;25:6267-6278.
16. Lin X, Miller J, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 2006;15:2087-2097.
17. Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB, et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci USA 2008; 105:20333-20338.
18. Charlet-B N, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002;10: 45-53.
19. Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 2003;11:113-126.
20. Adereth Y, Dammai V, Kose N, Li R, Hsu T. RNA-dependent integrin alpha3 protein localization regulated by the Muscleblind-like protein MLP1. Nat Cell Biol 2005;7:1240-1247.
21. Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000;289:1769-1772.
22. Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 2001;10:2717-2726.
23. Wang GS, Kearney DL, De Biasi M, Taffet G, Cooper TA. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest 2007;117:2802-2811.
24. Orengo JP, Chambon P, Metzger D, Mosier DR, Snipes GJ, Copper TA. Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci USA 2008;105:2646-2651.
25. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, et al. A muscleblind knockout model for myotonic dystrophy. Science 2003;302:1978-1980.
26. Hao M, Akrami K, Wei K, De Diego C, Che N, Ku JH, et al. Muscleblind-like 2 (Mbnl2)-deficient mice as a model for myotonic dystrophy. Dev Dyn 2008;237:403-410.
27. Timchenko NA, Patel R, Iakova P, Cai ZJ, Quan L, Timchenko LT. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 2004;279: 13129-12139.
28. Ho TH, Bundman D, Armstrong DA, Cooper TA. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 2005;14:1539-1547.
29. Jansen G, Groenen PJ, Bachner D, Jap PH, Coerwinkel M, Oerlemans F, et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet 1996;13: 316-324.
30. Reddy S, Smith DB, Rich MM, Leferovich JM, Reilly P, Davis BM, et al. Mice lacking the myotonic dystrophy protein kindase develop a late onset progressive myopathy. Nat Genet 1996;13:325-335.
31. Chen W, Wang Y, Abe Y, Cheney L, Udd B, Li YP. Haploin suffciency for Znf9 in Znf9 +/-mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J Mol Biol 2007;368: 8-17.
32. Guiraud-Dogan C, Huguet A, Gomes-Pereira M, Brisson E, Bassez G, Junien C, et al. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice. Biochim Biophys Acta 2007;1772:1183-1191.
33. Lueck JD, Mankodi A, Swanson M, Thornton C, Dirksen RT. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J Gen Physiol 2007;129:79-94.
34. Fuchtbauer EM, Reininghaus J, Jockusch H. Developmental control of the excitability of muscle: transplantation experiments on a myotonic mouse mutant. Proc Natl Acad Sci USA 1988;85:3880-3884.
35. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002;10:35-44.
36. Entrikin RK, Abresch RT, Sharman RB, Larson DB, Levine NA. Contractile and EMG studies of murine myotonia (mto) and muscular dystrophy (dy/dy). Muscle Nerve 1987;10:293-298.
37. Reininghaus J, Fuchtbauer EM, Bertram K, Jockusch H. The myotonic mouse mutant ADR: physiological and histochemical properties of muscle. Muscle Nerve 1988;11:433-439.
38. van Lunteren E, Pollarine J, Moyer M. Isotonic contractile impairment due to genetic CLC-1 chloride channel deficiency in myotonic mouse diaphragm muscle. Exp Physiol 2007;92:717-729.
39. van Lunteren E, Moyer M, Pollarine J. Genetic CLC-1 chloride channel deficiency modifies diaphragm muscle isometric contractile properties. Respir Physiol Neurobiol 2006;155:220-226.
40. Gordon DA, Enoka RN, Stuart DG. Motor-unit force potentiation in adult cats during a standard fatigue test. J Physiol Lond 1990;421:569-582.
41. Garner SH, Hicks AL, McComas AJ. Prolongation of twitch potentiating mechanisms throughout muscle fatigue and recovery. Exp Neurol 1989;103:277-281.
42. Rankin LL, Enoka KA, Volz KA, Stuart DG. Coexistence of twitch potentiation and tetanic force decline in rat hindlimb muscle. J Appl Physiol 1988;65:2687-2695.
43. van Lunteren E, Vafaie H. Force potentiation in respiratory muscles: comparison of diaphragm and sternohyoid. Am J Physiol 1993;264: R1095-R1100.
44. Torres C, Moxley RT, Griggs RC. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy. J Neurol Sci 1983;60:157-168.
45. Williams JH. Depression of posttetanic twitch potentiation by low calcium and calcium channel antagonists. J Appl Physiol 1990;69:1093-1097.
46. van Lunteren E., Elmslie KS, Jones SW. Effects of temperature on calcium current of bullfrog sympathetic neurons. J Physiol 1993;466:81-93.
47. Wheeler TM, Sobczak K, Lueck JD, Osborne RJ, Lin X, Dirksen RT, et al. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009;325:336-339.
48. Zifko UA, Hahn AF, Remtulla H, George CF, Wihlidal W, Bolton CF. Central and peripheral respiratory electrophysiological studies in myotonic dystrophy. Brain 1996;119:1911-1922.